Melphalan in Patients With Neoplastic Meningitis - Related Studies

Melphalan in Patients With Neoplastic Meningitis

This study is ongoing, but not recruiting participants.

Study NCT00002750. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Extragonadal Germ Cell Tumor
		Leukemia
		Lymphoma
		Metastatic Cancer
		Ovarian Cancer

2	Additional conditions recognized in this trial
		Central Nervous System Neoplasms
		Meningitis
		Neoplasm Metastasis
		Neoplasms, Germ Cell and Embryonal
		Nervous System Neoplasms
		Ovarian Neoplasms

3	More general conditions related to this trial
		Adnexal Diseases
		Central Nervous System Diseases
		Central Nervous System Infections
		Endocrine Gland Neoplasms
		Endocrine System Diseases
		Genital Diseases, Female
		Genital Neoplasms, Female
		Gonadal Disorders
		Immune System Diseases
		Immunoproliferative Disorders
		Lymphatic Diseases
		Lymphoproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplastic Processes
		Nervous System Diseases
		Ovarian Diseases
		Pathologic Processes
		Urogenital Neoplasms

4	Interventions listed in this trial
		melphalan

5	More general drug interventions related to this trial
		Alkylating Agents
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Myeloablative Agonists
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

6	Sponsors listed in this trial
		Duke University